Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Leukopenia as a Possible Biomarker for Overall Survival in Glioblastoma Patients Treated with Temozolomide
Neuro-oncology
P6 - (-)
167
Authors/Disclosures
Ka-wai G. Ho, MD (Beth Israel Deaconess Medical Center)
PRESENTER
No disclosure on file
Eric T. Wong, MD, FÂé¶¹´«Ã½Ó³»­ (Rhode Island Hospital) Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ZaiLab. Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Turning Point Therapeutics. Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imvax. The institution of Dr. Wong has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novocure. The institution of Dr. Wong has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Turning Point Therapeutics. The institution of Dr. Wong has received research support from Novocure. Dr. Wong has received intellectual property interests from a discovery or technology relating to health care. Dr. Wong has received publishing royalties from a publication relating to health care.
Erik Uhlmann, MD (Beth Israel Deaconess Medical Center) Dr. Uhlmann has nothing to disclose.